Загрузка...
MDR1 causes resistance to the antitumour drug miltefosine
Miltefosine (hexadecylphosphocholine) is used for topical treatment of breast cancers. It has been shown previously that a high percentage of breast carcinomas express MDR1 or MRP. We investigated the sensitivity of MDR1 -expressing cells to treatment with miltefosine. We show that cells overexpress...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group
2001
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2363649/ https://ncbi.nlm.nih.gov/pubmed/11355955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2001.1776 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|